A detailed history of Los Angeles Capital Management LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 78,440 shares of EOLS stock, worth $931,867. This represents 0.01% of its overall portfolio holdings.

Number of Shares
78,440
Previous 91,010 13.81%
Holding current value
$931,867
Previous $987,000 28.67%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$10.66 - $17.48 $133,996 - $219,723
-12,570 Reduced 13.81%
78,440 $1.27 Million
Q2 2024

Aug 05, 2024

SELL
$10.45 - $13.76 $472,507 - $622,172
-45,216 Reduced 33.19%
91,010 $987,000
Q1 2024

Apr 05, 2024

BUY
$9.99 - $14.91 $1.36 Million - $2.03 Million
136,226 New
136,226 $1.91 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $666M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.